Show simple item record

dc.contributor.authorCoe, P
dc.contributor.authorWilliams, S
dc.contributor.authorMorris, D
dc.contributor.authorParkin, Ed
dc.contributor.authorHarvie, M
dc.contributor.authorRenehan, Andrew G
dc.contributor.authorO'Reilly, D
dc.date.accessioned2018-05-10T20:28:28Z
dc.date.available2018-05-10T20:28:28Z
dc.date.issued2018-04-03
dc.identifier.citationDevelopment of MR quantified pancreatic fat deposition as a cancer risk biomarker. 2018, Pancreatologyen
dc.identifier.issn1424-3911
dc.identifier.pmid29655566
dc.identifier.doi10.1016/j.pan.2018.04.001
dc.identifier.urihttp://hdl.handle.net/10541/620998
dc.description.abstractExcess body adiposity is associated with increased risk of pancreatic cancer, and in animal models excess intra-pancreatic fat is a driver of pancreatic carcinogenesis. Within a programme to evaluate pancreatic fat and PC risk in humans, we assessed whether MR-quantified pancreatic fat fraction (PFF) was 'fit for purpose' as an imaging biomarker.
dc.language.isoenen
dc.rightsArchived with thanks to Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]en
dc.titleDevelopment of MR quantified pancreatic fat deposition as a cancer risk biomarker.en
dc.typeArticleen
dc.contributor.departmentDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UKen
dc.identifier.journalPancreatologyen
html.description.abstractExcess body adiposity is associated with increased risk of pancreatic cancer, and in animal models excess intra-pancreatic fat is a driver of pancreatic carcinogenesis. Within a programme to evaluate pancreatic fat and PC risk in humans, we assessed whether MR-quantified pancreatic fat fraction (PFF) was 'fit for purpose' as an imaging biomarker.


Files in this item

This item appears in the following Collection(s)

Show simple item record